Prospective study of delayed bleeding after colorectal EMR and polypectomy in patients receiving Rivaroxaban uninterruptedly before retiring

Trial Profile

Prospective study of delayed bleeding after colorectal EMR and polypectomy in patients receiving Rivaroxaban uninterruptedly before retiring

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Thromboembolism; Thrombosis
  • Focus Therapeutic Use
  • Acronyms RUBR
  • Most Recent Events

    • 21 Nov 2016 Status changed from not yet recruiting to recruiting.
    • 19 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top